Methylmalonic Acid Market
Methylmalonic Acid Market Size, Share & Trends Analysis Report by Application (Vitamin B12 Deficiency Testing, Clinical Analysis of Serum/Plasma, and Others), and by Purity (Above 96%, 96%, and Below 96%) Forecast Period, (2026-2035)
Industry Overview
Methylmalonic acid market was valued at $124.2 million in 2025 and is projected to reach $208.3 million by 2035, growing at a CAGR of 5.4% during the forecast period (2026-2035). The global methylmalonic acid market is expanding primarily due to the increasing demand for accurate diagnostic testing of vitamin B12 deficiency. Elevated awareness among healthcare providers and patients regarding the clinical significance of methylmalonic acid as a sensitive biomarker has led to broader adoption in routine laboratory analysis. This trend is further reinforced by the growing prevalence of metabolic disorders and related conditions, which has heightened the need for precise clinical monitoring. In addition, advancements in analytical instrumentation and standardized assay protocols have improved testing efficiency and reliability, supporting higher market uptake.
Market Dynamics
Expansion of Research and Clinical Applications
The market is benefiting from increased utilization of methylmalonic acid in biomedical research and clinical studies. Growing interest in metabolic pathway analysis, nutritional research, and inborn errors of metabolism has created a steady demand for high-purity methylmalonic acid reagents. Laboratories are adopting MMA for method development, assay validation, and comparative studies, extending its applications beyond routine diagnostics. This trend is supported by the availability of certified reference materials and standardized testing protocols. As research requirements expand, suppliers are increasingly offering diverse product grades, further driving market adoption.
Rising Adoption of High-Purity Standards in Diagnostic Testing
The demand for methylmalonic acid with purities above 96% is rising as laboratories seek more precise and reliable diagnostic outcomes. Clinical facilities and reference laboratories are emphasizing the use of high-purity MMA to improve assay accuracy for vitamin B12 deficiency and metabolic disorder screening. Technological improvements in chemical synthesis and purification have made these high-grade standards more accessible, enabling wider use across multiple applications. The trend is reinforced by regulatory guidance and quality benchmarks that encourage consistent reagent quality.
Market Segmentation
- Based on the application, the market is segmented into vitamin B12 deficiency testing, clinical analysis of serum/plasma, and others.
- Based on the purity, the market is segmented into above 96%, 96%, and below 96%.
Vitamin B12 Deficiency Testing: Leading Application Sub-Segment
The vitamin B12 deficiency testing sub-segment is a primary driver of market growth due to its clinical relevance in diagnosing borderline or ambiguous B12 levels. The increasing prevalence of nutritional deficiencies and age-related metabolic disorders has expanded demand for sensitive biomarkers such as methylmalonic acid. Laboratories are increasingly adopting MMA testing to complement traditional B12 assays, ensuring more accurate diagnosis and patient management. Recent improvements in assay standardization and automation have further enhanced testing efficiency and throughput. Consequently, this sub-segment remains central to the market’s expansion and underpins overall application demand.
Above 96% Purity: Leading Type Sub-Segment
The above 96% purity sub-segment is witnessing strong growth driven by the need for highly accurate and reliable clinical and research assays. High-purity methylmalonic acid is preferred in diagnostic laboratories and reference testing due to its ability to minimize analytical errors and improve assay reproducibility. Suppliers have responded with enhanced synthesis and purification techniques, making these standards more accessible and consistent across global markets. Regulatory emphasis on quality and laboratory accreditation further supports the adoption of high-purity products. As a result, this sub-segment commands a significant share and plays a critical role in market revenue generation.
Regional Outlook
The global methylmalonic acid market is further divided by geography, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
North America: Leading Regional Market for Methylmalonic Acid
North America is the largest regional market for methylmalonic acid, driven by the widespread adoption of advanced diagnostic testing and high awareness of vitamin B12 deficiency among healthcare providers. The presence of well-established clinical laboratories and robust research infrastructure has supported consistent demand for high-purity MMA reagents. Recent developments include the integration of automated analytical platforms that enhance testing efficiency and accuracy across hospitals and diagnostic centers. Key industry participants operating in this region include Thermo Fisher Scientific Inc., Merck KGaA, and Avantor, Inc. The combination of strong healthcare infrastructure, regulatory support, and supplier availability underpins North America’s leading position in the global market.
Asia-Pacific: Fastest-Growing Regional Market for Methylmalonic Acid
Asia-Pacific is the fastest-growing market for methylmalonic acid, fueled by increasing awareness of nutritional deficiencies, expanding clinical diagnostics, and a rising prevalence of metabolic disorders. Rapid growth in research laboratories and academic institutions has further stimulated demand for MMA reagents, particularly high-purity grades. Recent expansions by suppliers, including TCI Chemicals (Tokyo Chemical Industry Co., Ltd.) and regional distributors, have improved product accessibility across China, India, Japan, and ASEAN countries. Investment in laboratory infrastructure and the adoption of standardized testing protocols are additional drivers accelerating market growth.
Market Players Outlook
The major companies operating in the global Methylmalonic Acid market include Avantor, Inc., Merck KGaA, TCI Chemicals, Thermo Fisher Scientific Inc., among others. Market players are leveraging partnerships, collaborations, mergers and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Developments
- In October 2025, Thermo Fisher Scientific acquired Clario Holdings for $8.875 billion in cash, with potential additional payments based on performance. Clario provides endpoint data solutions for clinical trials, integrating data from devices, sites, and patients to help pharma and biotech companies manage and analyze clinical evidence digitally. Its platform has supported about 70% of FDA drug approvals in the past decade, enhancing trial decision-making across drug development phases.
- In September 2025, MilliporeSigma, Merck KGaA's U.S. and Canada Life Science business, opened a €150 million climate-neutral filtration manufacturing facility in Cork, Ireland. The 3,000-square-meter cleanroom will produce critical filtration products for vaccines, monoclonal antibodies, and advanced therapies like cell and gene therapies.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global methylmalonic acid market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Global Methylmalonic Acid Market Sales Analysis – Application | Resolution | Purity ($ Million)
- Methylmalonic Acid Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Methylmalonic Acid Market Trends
- Market Recommendations
- Porter's Five Forces Analysis for the Methylmalonic Acid Market
- Competitive Rivalry
- Threat of New Entrants
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Market Determinants
- Market Drivers
- Drivers For Global Methylmalonic Acid Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Global Methylmalonic Acid Market: Impact Analysis
- Market Opportunities
- Opportunities For Global Methylmalonic Acid Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Methylmalonic Acid Market Revenue and Share by Manufacturers
- Methylmalonic Acid Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Avantor, Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Merck KGaA
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- TCI Chemicals
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Thermo Fisher Scientific Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- Avantor, Inc.
- Key Company Analysis
- Global Methylmalonic Acid Market Sales Analysis by Application ($ Million)
- Vitamin B12 Deficiency Testing
- Clinical Analysis of Serum/Plasma
- Others
- Global Methylmalonic Acid Market Sales Analysis by Purity ($ Million)
- Above 96%
- 96%
- Below 96%
- Regional Analysis
- North American Methylmalonic Acid Market Sales Analysis – Application | Purity | Country ($ Million)
- Macroeconomic Factors for North America
- United States
- Canada
- European Methylmalonic Acid Market Sales Analysis – Application | Purity | Country ($ Million)
- Macroeconomic Factors for Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia-Pacific Methylmalonic Acid Market Sales Analysis – Application | Purity | Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- Rest of Asia-Pacific
- Rest of the World Methylmalonic Acid Market Sales Analysis – Application | Purity | Country ($ Million)
- Macroeconomic Factors for Rest of the World
- Latin America
- Middle East and Africa
- Company Profiles
- Avantor, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Biosynth AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Cambridge Isotope Laboratories, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Cayman Chemical Company
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Chiron AS
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- FUJIFILM Holdings Corp. (FUJIFILM Wako Pure Chemical Corp.)
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- LGC Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Merck KGaA (MilliporeSigma)
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Nacalai Tesque, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Spectrum Chemical Manufacturing Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- SynZeal Research Pvt. Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- SyTracks A/S
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- TCI Chemicals (Tokyo Chemical Industry Co., Ltd.)
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Thermo Fisher Scientific Inc. (Alfa Aesar/Thermo Scientific Chemicals)
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Toronto Research Chemicals Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Wuhan Fine Biotech Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Xiamen Hisunny Chemical Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Zhejiang Jiahua Energy Chemical Industry Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Avantor, Inc.
1. Global Methylmalonic Acid Market Research and Analysis by Application, 2025–2035 ($ Million)
2. Global Methylmalonic Acid For Vitamin B12 Deficiency Testing Market Research and Analysis by Region, 2025–2035 ($ Million)
3. Global Methylmalonic Acid For Clinical Analysis of Serum/Plasma Market Research and Analysis by Region, 2025–2035 ($ Million)
4. Global Methylmalonic Acid For Other Applications Market Research and Analysis by Region, 2025–2035 ($ Million)
5. Global Methylmalonic Acid Market Research and Analysis by Purity, 2025–2035 ($ Million)
6. Global Methylmalonic Acid – Above 96% Market Research and Analysis by Region, 2025–2035 ($ Million)
7. Global Methylmalonic Acid – 96% Market Research and Analysis by Region, 2025–2035 ($ Million)
8. Global Methylmalonic Acid – Below 96% Market Research and Analysis by Region, 2025–2035 ($ Million)
9. Global Methylmalonic Acid Market Research and Analysis by Region, 2025–2035 ($ Million)
10. North American Methylmalonic Acid Market Research and Analysis by Country, 2025–2035 ($ Million)
11. North American Methylmalonic Acid Market Research and Analysis by Application, 2025–2035 ($ Million)
12. North American Methylmalonic Acid Market Research and Analysis by Purity, 2025–2035 ($ Million)
13. European Methylmalonic Acid Market Research and Analysis by Country, 2025–2035 ($ Million)
14. European Methylmalonic Acid Market Research and Analysis by Application, 2025–2035 ($ Million)
15. European Methylmalonic Acid Market Research and Analysis by Purity, 2025–2035 ($ Million)
16. Asia-Pacific Methylmalonic Acid Market Research and Analysis by Country, 2025–2035 ($ Million)
17. Asia-Pacific Methylmalonic Acid Market Research and Analysis by Application, 2025–2035 ($ Million)
18. Asia-Pacific Methylmalonic Acid Market Research and Analysis by Purity, 2025–2035 ($ Million)
19. Rest of the World Methylmalonic Acid Market Research and Analysis by Region, 2025–2035 ($ Million)
20. Rest of the World Methylmalonic Acid Market Research and Analysis by Application, 2025–2035 ($ Million)
21. Rest of the World Methylmalonic Acid Market Research and Analysis by Purity, 2025–2035 ($ Million)
1. Global Methylmalonic Acid Market Share by Application, 2025 vs 2035 (%)
2. Global Methylmalonic Acid For Vitamin B12 Deficiency Testing Market Share by Region, 2025 vs 2035 (%)
3. Global Methylmalonic Acid For Clinical Analysis of Serum/Plasma Market Share by Region, 2025 vs 2035 (%)
4. Global Methylmalonic Acid For Other Applications Market Share by Region, 2025 vs 2035 (%)
5. Global Methylmalonic Acid Market Share by Purity, 2025 vs 2035 (%)
6. Global Methylmalonic Acid – Above 96% Market Share by Region, 2025 vs 2035 (%)
7. Global Methylmalonic Acid – 96% Market Share by Region, 2025 vs 2035 (%)
8. Global Methylmalonic Acid – Below 96% Market Share by Region, 2025 vs 2035 (%)
9. Global Methylmalonic Acid Market Research and Analysis by Region, 2025–2035 ($ Million)
10. US Methylmalonic Acid Market Size, 2025–2035 ($ Million)
11. Canada Methylmalonic Acid Market Size, 2025–2035 ($ Million)
12. UK Methylmalonic Acid Market Size, 2025–2035 ($ Million)
13. France Methylmalonic Acid Market Size, 2025–2035 ($ Million)
14. Germany Methylmalonic Acid Market Size, 2025–2035 ($ Million)
15. Italy Methylmalonic Acid Market Size, 2025–2035 ($ Million)
16. Spain Methylmalonic Acid Market Size, 2025–2035 ($ Million)
17. Russia Methylmalonic Acid Market Size, 2025–2035 ($ Million)
18. Rest of Europe Methylmalonic Acid Market Size, 2025–2035 ($ Million)
19. India Methylmalonic Acid Market Size, 2025–2035 ($ Million)
20. China Methylmalonic Acid Market Size, 2025–2035 ($ Million)
21. Japan Methylmalonic Acid Market Size, 2025–2035 ($ Million)
22. South Korea Methylmalonic Acid Market Size, 2025–2035 ($ Million)
23. Australia and New Zealand Methylmalonic Acid Market Size, 2025–2035 ($ Million)
24. ASEAN Economies Methylmalonic Acid Market Size, 2025–2035 ($ Million)
25. Rest of Asia-Pacific Methylmalonic Acid Market Size, 2025–2035 ($ Million)
26. Latin America Methylmalonic Acid Market Size, 2025–2035 ($ Million)
27. Middle East and Africa Methylmalonic Acid Market Size, 2025–2035 ($ Million)
- Printable version
- No restriction to number of user within the company
Contact Sales
FAQS
The size of the Methylmalonic Acid Market in 2025 is estimated to be around $124.2 million.
North America holds the largest share in the Methylmalonic Acid Market.
Leading players in the Methylmalonic Acid Market include Avantor, Inc., Merck KGaA, TCI Chemicals, Thermo Fisher Scientific Inc., among others.
The Methylmalonic Acid Market is expected to grow at a CAGR of 5.4% from 2026 to 2035.
The Methylmalonic Acid Market growth is driven by increasing demand for metabolic disorder diagnostics and growing use in clinical and research laboratory applications.
